Inhibition of human gingival carcinoma cell growth by prostaglandins. 1988

K Suzuki, and N Kobayashi, and Y Moriya, and Y Abiko, and H Suzuki
Department of Head and Neck Surgery, Nihon University School of Dentistry, Chiba, Japan.

The inhibitory effects of various prostaglandins (PGA2, PGD2 and PGE2) on the growth of human gingival carcinoma cell line Ca 9-22 and human cervical carcinoma cell line HeLa were studied in vitro. 1. PGA2 and PGD2 significantly depressed Ca 9-22 cell proliferation in dose and time related fashion. 2. The inhibitory rate by PGs for Ca 9-22 cells exceeded than HeLa-cells. 3. IC50 value of PGD2 on growth of Ca 9-22 was calculated to be 4 micrograms/ml.

UI MeSH Term Description Entries
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011454 Prostaglandins A (13E,15S)-15-Hydroxy-9-oxoprosta-10,13-dien-1-oic acid (PGA(1)); (5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oic acid (PGA(2)); (5Z,13E,15S,17Z)-15-hydroxy-9-oxoprosta-5,10,13,17-tetraen-1-oic acid (PGA(3)). A group of naturally occurring secondary prostaglandins derived from PGE; PGA(1) and PGA(2) as well as their 19-hydroxy derivatives are found in many organs and tissues. PGA
D011457 Prostaglandins D Physiologically active prostaglandins found in many tissues and organs. They show pressor activity, are mediators of inflammation, and have potential antithrombotic effects. PGD
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005887 Gingival Neoplasms New abnormal growth of tissue in the GINGIVA. Epulis, Congenital,Congenital Epulides,Congenital Epulis,Epulides, Congenital,Neoplasms, Gingival,Gingival Neoplasm,Neoplasm, Gingival
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015230 Prostaglandin D2 The principal cyclooxygenase metabolite of arachidonic acid. It is released upon activation of mast cells and is also synthesized by alveolar macrophages. Among its many biological actions, the most important are its bronchoconstrictor, platelet-activating-factor-inhibitory, and cytotoxic effects. 11-Dehydroprostaglandin F2alpha,PGD2,11-Dehydroprostaglandin F2 alpha,11 Dehydroprostaglandin F2 alpha,11 Dehydroprostaglandin F2alpha,D2, Prostaglandin,F2 alpha, 11-Dehydroprostaglandin,F2alpha, 11-Dehydroprostaglandin,alpha, 11-Dehydroprostaglandin F2

Related Publications

K Suzuki, and N Kobayashi, and Y Moriya, and Y Abiko, and H Suzuki
July 1985, Seikagaku. The Journal of Japanese Biochemical Society,
K Suzuki, and N Kobayashi, and Y Moriya, and Y Abiko, and H Suzuki
February 1989, Prostaglandins, leukotrienes, and essential fatty acids,
K Suzuki, and N Kobayashi, and Y Moriya, and Y Abiko, and H Suzuki
January 1994, Anticancer research,
K Suzuki, and N Kobayashi, and Y Moriya, and Y Abiko, and H Suzuki
May 2000, Wei sheng yan jiu = Journal of hygiene research,
K Suzuki, and N Kobayashi, and Y Moriya, and Y Abiko, and H Suzuki
September 1995, Journal of periodontal research,
K Suzuki, and N Kobayashi, and Y Moriya, and Y Abiko, and H Suzuki
September 1983, Gan to kagaku ryoho. Cancer & chemotherapy,
K Suzuki, and N Kobayashi, and Y Moriya, and Y Abiko, and H Suzuki
May 2009, Molecular biology reports,
K Suzuki, and N Kobayashi, and Y Moriya, and Y Abiko, and H Suzuki
October 2000, European journal of cancer (Oxford, England : 1990),
K Suzuki, and N Kobayashi, and Y Moriya, and Y Abiko, and H Suzuki
January 1987, Infection and immunity,
K Suzuki, and N Kobayashi, and Y Moriya, and Y Abiko, and H Suzuki
November 1998, Journal of periodontal research,
Copied contents to your clipboard!